2025
SJR Q3
JCR Q3 · 2,6
328 matched articles
SCIE
Journal detail
Anti-Cancer Agents in Medicinal Chemistry
- Publisher
- Bentham Science Publishers
- Country
- United Arab Emirates · Middle East
- Type
- journal
- ISSN
-
1871520618755992
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,584
- Quartile Q3
- H-Index 117
- Cites/doc 2,76
- Docs (3y) 612
- Cites (3y) 2.011
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,6
- 5Y JIF 2,8
- JCI 0,56
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Cancer Research Q3
- Molecular Medicine Q3
- Pharmacology Q3
Areas
- Biochemistry, Genetics and Molecular Biology
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Oncology | Chemistry, Medicinal
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q3 | Q3 | 0,584 | 2,6 | 2,8 | 0,56 | Q3 | 117 |
| 2024 | Q3 | Q2 | 0,562 | 3 | 2,8 | 0,59 | Q3 | 113 |
| 2023 | Q3 | Q3 | 0,503 | 2,6 | 2,5 | 0,6 | Q3 | 113 |
| 2022 | Q3 | Q3 | 0,428 | 2,8 | 2,7 | 0,54 | Q3 | 113 |
| 2021 | Q3 | Q3 | 0,403 | 2,5 | 2,8 | 0,51 | Q3 | 113 |
| 2020 | Q3 | Q3 | 0,508 | 2,5 | 2,7 | 0,52 | Q3 | 113 |
| 2019 | Q3 | Q3 | 0,543 | 2 | 2,3 | 0,57 | Q3 | 113 |
| 2018 | — | Q3 | — | 2,2 | 2,4 | 0,64 | Q3 | — |
| 2017 | Q2 | Q3 | 0,674 | 2,6 | 2,6 | 0,8 | Q2 | 113 |
| 2016 | Q2 | Q2 | 0,807 | 2,6 | 2,7 | — | — | 113 |
| 2015 | Q2 | Q2 | 0,978 | 2,7 | 2,8 | — | — | 113 |
| 2014 | Q2 | Q2 | 0,963 | 2,5 | 3 | — | — | 113 |
| 2013 | Q1 | Q2 | 1,122 | 2,9 | 3,4 | — | — | 113 |
| 2012 | Q2 | Q2 | 1,027 | 2,6 | — | — | — | 113 |
| 2011 | Q1 | Q2 | 1,341 | 2,9 | — | — | — | 113 |
| 2010 | Q1 | Q1 | 1,354 | 3,1 | — | — | — | 113 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 48/72 |
| 2025 | ONCOLOGY | SCIE | Q3 | Q3 | 196/333 |
| 2024 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 44/72 |
| 2024 | ONCOLOGY | SCIE | Q2 | Q3 | 145/328 |
| 2023 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 44/72 |
| 2023 | ONCOLOGY | SCIE | Q3 | Q3 | 175/322 |
| 2022 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 40/60 |
| 2022 | ONCOLOGY | SCIE | Q3 | Q3 | 168/241 |
| 2021 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q4 | 47/63 |
| 2021 | ONCOLOGY | SCIE | Q4 | Q3 | 201/245 |
| 2020 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q4 | 45/62 |
| 2020 | ONCOLOGY | SCIE | Q4 | Q3 | 207/242 |
| 2019 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 43/61 |
| 2019 | ONCOLOGY | SCIE | Q4 | Q3 | 198/244 |
| 2018 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q3 | 39/61 |
| 2018 | ONCOLOGY | SCIE | Q4 | Q3 | 173/230 |
| 2017 | CHEMISTRY, MEDICINAL | SCIE | Q3 | Q2 | 32/59 |
| 2017 | ONCOLOGY | SCIE | Q3 | Q2 | 146/223 |
| 2016 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 30/60 |
| 2016 | ONCOLOGY | SCIE | Q3 | — | 130/217 |
| 2015 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 27/59 |
| 2015 | ONCOLOGY | SCIE | Q3 | — | 118/213 |
| 2014 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 29/59 |
| 2014 | ONCOLOGY | SCIE | Q3 | — | 124/211 |
| 2013 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 22/58 |
| 2013 | ONCOLOGY | SCIE | Q2 | — | 85/203 |
| 2012 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 26/59 |
| 2012 | ONCOLOGY | SCIE | Q3 | — | 99/197 |
| 2011 | CHEMISTRY, MEDICINAL | SCIE | Q2 | — | 23/59 |
| 2011 | ONCOLOGY | SCIE | Q2 | — | 82/196 |
| 2010 | CHEMISTRY, MEDICINAL | SCIE | Q1 | — | 12/54 |
| 2010 | ONCOLOGY | SCIE | Q2 | — | 67/185 |